AdvisorShares Trust (NASDAQ: SILO) holds 6.69% of Silo Pharma

Rhea-AI Filing Summary

AdvisorShares Trust filed a Schedule 13G reporting beneficial ownership of 6.69% of Silo Pharma, Inc. The filing shows 75,582 shares of common stock (CUSIP 82711P300) as beneficially owned as of 06/30/2026. The report is signed by Stefanie Little, Chief Compliance Officer, on 07/08/2026.

Insights

Institutional Ownership Analyst

Large passive holding disclosed: 75,582 shares, 6.69% ownership.

The filing records AdvisorShares Trust as beneficial owner of 6.69% of the company's common stock, totaling 75,582 shares as of 06/30/2026. The Schedule 13G format typically indicates passive or passive-investor status under SEC rules.

Key dependencies: whether this represents index/ETF exposure or a portfolio position; subsequent filings could show changes. Cash-flow treatment and any voting arrangements beyond sole voting power are not detailed beyond the listed share counts.

Compliance & Registry Specialist

Filing attributes sole voting and dispositive power to the filer.

The report lists 75,582 shares with sole voting and sole dispositive power, and provides the filer address in Bethesda, Maryland. CUSIP 82711P300 is cited for precise security identification.

Filing signature dated 07/08/2026 completes the reporting requirement for the 06/30/2026 reporting period; any change in ownership would require an amended disclosure per SEC rules.

Key Figures

Beneficial ownership: 75,582 shares Percent of class: 6.69% CUSIP: 82711P300 +2 more

5 metrics

Beneficial ownership 75,582 shares as of 06/30/2026

Percent of class 6.69% reported ownership percentage

CUSIP 82711P300 security identifier for common stock

Filing signature date 07/08/2026 date signed by Chief Compliance Officer

Reporting date 06/30/2026 ownership as of date stated in the form

Key Terms

Schedule 13G, Beneficial ownership, CUSIP, Sole dispositive power

4 terms

Schedule 13G regulatory

"Item 1. Name of issuer: Silo Pharma, Inc.; header shows SCHEDULE 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficial ownership financial

"Item 4. Amount beneficially owned: 75,582"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

CUSIP regulatory

"CUSIP Number(s): 82711P300"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

Sole dispositive power regulatory

"Item 4. (iii) Sole power to dispose or to direct the disposition of: 75,582"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 05:23 PM Accepted by SEC EDGAR 07/08/2026 - 05:22 PM Learn about SEC filing dates

FAQ

What stake does AdvisorShares Trust report in Silo Pharma (SILO)?

AdvisorShares Trust reports beneficial ownership of 75,582 shares, representing 6.69% of Silo Pharma's common stock as disclosed in the filing.

As of what date is the 6.69% ownership reported?

The Schedule 13G states the ownership figure is reported as of 06/30/2026, with the filing signed on 07/08/2026 by the Chief Compliance Officer.

Who signed the Schedule 13G for AdvisorShares Trust?

Stefanie Little, identified as Chief Compliance Officer, signed the filing on 07/08/2026, certifying the reported beneficial ownership and powers listed.

What voting and dispositive powers are reported for the 75,582 shares?

The filing lists sole voting power for 75,582 shares and sole dispositive power for 75,582 shares; no shared voting or dispositive power is reported.

What CUSIP identifies the reported security?

The Schedule 13G cites CUSIP 82711P300 for Silo Pharma's common stock, matching the class of securities described in the filing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Silo Pharma, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

82711P300

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 82711P300

1

Names of Reporting Persons

AdvisorShares Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 75,582.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 75,582.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

75,582.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.69 %

12

Type of Reporting Person (See Instructions)

IV

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Silo Pharma, Inc.
(b)	Address of issuer's principal executive offices: 677 N. Washington Boulevard, Sarasota, Florida, 34236
Item 2.
(a)	Name of person filing: AdvisorShares Trust
(b)	Address or principal business office or, if none, residence: 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP Number(s): 82711P300
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 75,582
(b)	Percent of class: 6.69 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 75,582
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 75,582
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AdvisorShares Trust

Signature:	/s/ Stefanie Little
Name/Title:	Stefanie Little - Chief Compliance Officer
Date:	07/08/2026